Cited by 1,052Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesSmoking Behavior and Cessation

The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.

Mortality in COPD: role of comorbidities

Open access

Sin, D. D., Anthonisen, N. R., Soriano, J. B., Agusti, A. G.·2006·European Respiratory Journal

DOI 10.1183/09031936.00133805

Open this paper in CoChat — free account Open PDF

Abstract

Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of the difficulties associated with identifying the precise cause of death. Respiratory failure is considered the major cause of death in advanced COPD. Comorbidities such as cardiovascular disease and lung cancer are also major causes and, in mild-to-moderate COPD, are the leading causes of mortality. The links between COPD and these conditions are not fully understood. However, a link through the inflammation pathway has been suggested, as persistent low-grade pulmonary and systemic inflammation, both known risk factors for cardiovascular disease and cancer, are present in COPD independent of cigarette smoking. Lung-specific measurements, such as forced expiratory volume in one second (FEV(1)), predict mortality in COPD and in the general population. However, composite tools, such as health-status measurements (e.g. St George's Respiratory Questionnaire) and the BODE index, which incorporates Body mass index, lung function (airflow Obstruction), Dyspnoea and Exercise capacity, predict mortality better than FEV(1) alone. These multidimensional tools may be more valuable because, unlike predictive approaches based on single parameters, they can reflect the range of comorbidities and the complexity of underlying mechanisms associated with COPD. The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructive pulmonary disease and comorbid conditions (i.e. inflammation), and the tools used to predict chronic obstructive pulmonary disease mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1183/09031936.00133805

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F. S. F., Utokaparch, S., Woods, R. R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,828

Show all 142 references

Research works printed but not linked: 11

1997, Monaldi Arch Chest Dis, 52, 43
1998, Monaldi Arch Chest Dis, 53, 324
1999, Eur Respir J, 14, 387s
10.1001/jama.1994.03520190043033 · DOI
2000, J Am Geriatr Soc, 48, S91
European Respiratory Society, European Lung Foundation. Loddenkemper R, Gibson GJ, Sibille Y, eds. Lung Health in Europe Facts and Figures. Sheffield, ERSJ, 2003; pp. 34–43
2004, Chest, 125, 134S
1998, Int J Mol Med, 2, 715
2001, Chest, 119, 1294
1995, Oncogene, 11, 999
1978, Scand J Respir Dis, 59, 154

Sorted by citations

Items 301–400 of 999

Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy
Fedeli, U., Giorgi, A. D., Gennaro, N., Ferroni, E., Gallerani, M., Mikhailidis, D. P., Manfredini, R., & Fabbian, F. (2017) · International Journal of COPD · doi:10.2147/copd.s119390 · Cited by 33
Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
Kopsaftis, Z., Sulaiman, N. S., Mountain, O., Carson‐Chahhoud, K., Phillips, P. A., & Smith, B. J. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0860-0 · Cited by 33
FEV1 and total Cardiovascular mortality and morbidity over an 18 years follow-up Population-Based Prospective EPIC-NORFOLK Study
Ching, S. M., Chia, Y. C., Lentjes, M. A. H., Luben, R., Wareham, N. J., & Khaw, K. (2019) · BMC Public Health · doi:10.1186/s12889-019-6818-x · Cited by 33
Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function
Spilling, C. A., Bajaj, M.-P. K., Burrage, D., Ruickbie, S., Thai, N. J., Baker, E. H., Jones, P., Barrick, T. R., & Dodd, J. W. (2019) · International Journal of COPD · doi:10.2147/copd.s213607 · Cited by 32
Silica dust, radon and death from non-malignant respiratory diseases in German uranium miners
Kreuzer, M., Sogl, M., Brüske, I., Möhner, M., Nowak, D., Schnelzer, M., & Walsh, L. (2013) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-101582 · Cited by 33
Understanding COPD: A vision on phenotypes, comorbidities and treatment approach
Fragoso, E., André, S., Boléo-Tomé, J. P., Areias, V., Munhá, J., Cardoso, J., & Crónica, O. B. O. G. D.-G. D. I. N. D. P. O. (2016) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2015.12.001 · Cited by 34
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
Waschki, B., Watz, H., Holz, O., MAGNUSSEN, H., Olejnicka, B. T., Welte, T., Rabe, K. F., & Janciauskiene, S. M. (2017) · International Journal of COPD · doi:10.2147/copd.s128689 · Cited by 33
Retinal oximetry and systemic arterial oxygen levels
Eliasdottir, T. S. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13932 · Cited by 34
COPD is associated with increased cardiovascular disease risk independent of phenotype
Cobb, K., Kenyon, J., Lü, J., Krieger, B., Perelas, A., Nana-Sinkam, P. S., Kim, Y., & Rodriguez‐Miguelez, P. (2024) · Respirology · doi:10.1111/resp.14799 · Cited by 32
The Challenge of Controlling the COPD Epidemic: Unmet Needs
Polverino, F., & Celli, B. R. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.05.001 · Cited by 32
Cascading Feedback: A Longitudinal Study of a Feedback Ecosystem for Telemonitoring Patients with Chronic Disease
Brohman, M. K., Addas, S., Dixon, J., & Pinsonneault, A. (2020) · MIS Quarterly · doi:10.25300/misq/2020/15089 · Cited by 44
A Guide to Guidelines for Professional Societies and Other Developers of Recommendations: Introduction to Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
Schünemann, H. J., Woodhead, M. A., Anzueto, A., Buist, A. S., MacNee, W., Rabe, K. F., & Heffner, J. E. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201208-053st · Cited by 32
Abnormal heart rate recovery and chronotropic incompetence on exercise in chronic obstructive pulmonary disease
Gupta, M., Bansal, V., & Chhabra, S. K. (2013) · Chronic Respiratory Disease · doi:10.1177/1479972313493097 · Cited by 32
Cáncer de pulmón y EPOC: una asociación frecuente
Arca, J. A., Lamelas, I. P., Ortega, R., Pérez, J. J. B., Navarro, M. E. T., & Velázquez, P. M. (2009) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2009.07.005 · Cited by 32
Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011)
Lee, D.-W., & Choi, E.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164303 · Cited by 34
Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease
Čelutkienė, J., Balčiūnas, M., Kablučko, D., Vaitkevičiūtė, L., Vaitkevičiūte, J. B., & Danila, E. (2017) · Cardiac failure review · doi:10.15420/cfr.2016:23:2 · Cited by 32
Cardiac Troponin-I Predicts Long-Term Mortality in Chronic Obstructive Pulmonary Disease
Fruchter, O., & Yigla, M. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902902620 · Cited by 31
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome
Voulgaris, A., Archontogeorgis, K., Steiropoulos, P., & Παπάνας, Ν. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200318103553 · Cited by 44
Evidence-based risk assessment and recommendations for physical activity clearance: respiratory disease1This paper is one of a selection of papers published in the Special Issue entitled Evidence-based risk assessment and recommendations for physical activity clearance, and has undergone the Journal’s usual peer-review process.
Eves, N. D., & Davidson, W. J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-057 · Cited by 35
Peak flow as a predictor of cause-specific mortality in China: results from a 15-year prospective study of ∼170 000 men
Smith, M. C., Zhou, M., Wang, L., Peto, R., Yang, G., & Chen, Z. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt079 · Cited by 31
Palliative Care and Pulmonary Rehabilitation
Janssen, D. J. A., & McCormick, J. R. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.02.006 · Cited by 31
Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study
Kaszuba, E., Odeberg, H., Råstam, L., & Halling, A. (2018) · BMC Family Practice · doi:10.1186/s12875-018-0865-8 · Cited by 31
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
Miravitlles, M., Price, D. B., Rabe, K. F., Schmidt, H., Metzdorf, N., & Celli, B. R. (2015) · International Journal of COPD · doi:10.2147/copd.s71913 · Cited by 30
The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
Sawalha, S., Hedman, L., Bäckman, H., Stenfors, N., Rönmark, E., Lundbäck, B., & Lindberg, A. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466619860058 · Cited by 30
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients
Kreivi, H., Itäluoma, T., & Bachour, A. (2020) · ERJ Open Research · doi:10.1183/23120541.00101-2019 · Cited by 30
Multimorbidity clusters in patients with chronic obstructive airway diseases in the EpiChron Cohort
Carmona‐Pírez, J., Poblador‐Plou, B., Ioakeim‐Skoufa, I., González‐Rubio, F., Gimeno-Feliú, L. A., Díez‐Manglano, J., Laguna-Berna, C., Marín, J. M., Miguel, A. G., & Prados‐Torres, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-83964-w · Cited by 30
Red cell distribution in critically ill patients with chronic obstructive pulmonary disease
Lan, W., Liu, E., Sun, D., Li, W., Zhu, J., Zhou, J., Jin, M., & Jiang, W. (2022) · Pulmonology · doi:10.1016/j.pulmoe.2022.04.001 · Cited by 30
Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities
Young, R. P., & Hopkins, R. J. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2013.838018 · Cited by 31
High COPD Prevalence in Patients with Liver Disease
Minakata, Y., Ueda, H., Akamatsu, K., Kanda, M., Yanagisawa, S., Ichikawa, T., Koarai, A., Hirano, T., Sugiura, H., Matsunaga, K., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3948 · Cited by 30
Fetuin-A is Associated with Disease Severity and Exacerbation Frequency in Patients with COPD
Minas, M., Mystridou, P., Georgoulias, P., Pournaras, S., Κostikas, Κ., & Gourgoulianis, K. I. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.727922 · Cited by 30
Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study
Kim, B., Lee, H. J., Kang, M. G., Kim, J. S., & Moon, J. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e344 · Cited by 29
Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease
Doehner, W., Hæusler, K. G., Endres, M., Anker, S. D., MacNee, W., & Lainščak, M. (2011) · Respiratory Medicine · doi:10.1016/s0954-6111(11)70005-1 · Cited by 29
A Qualitative Interpretation of Challenges Associated with Helping Patients with Multiple Chronic Diseases Identify Their Goals
Boeckxstaens, P., Willems, S. J. T., Lanssens, M., Decuypere, C., Brusselle, G., Kühlein, T., Maeseneer, J. D., & Sutter, A. D. (2016) · Journal of Comorbidity · doi:10.15256/joc.2016.6.64 · Cited by 29
COPD Course and Comorbidities: Are There Gender Differences?
Grabicki, M., Kuźnar-Kamińska, B., Rubinsztajn, R., Brajer-Luftmann, B., Kosacka, M., Nowicka, A., Piorunek, T., Kostrzewska, M., Chazan, R., & Batura‐Gabryel, H. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_160 · Cited by 39
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?
Vasileiadis, I. E., Goudis, C. A., Giannakopoulou, P., & Liu, T. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1432034 · Cited by 30
Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease
Wise, R. A., Chapman, K. R., Scirica, B. M., Bhatt, D. L., Daoud, S. Z., Zetterstrand, S., Reisner, C., & Gil, E. G. (2019) · JAMA · doi:10.1001/jama.2019.4973 · Cited by 29
Ultrasound Shear Wave Elastography for Evaluation of Diaphragm Stiffness in Patients with Stable COPD : A Pilot Trial
Xu, J., Wu, Z., Tao, F.-Y., Zhu, S., Chen, S., Cai, C., Liang, Z., Shi, B., Chen, B., & Xie, Y. (2021) · Journal of Ultrasound in Medicine · doi:10.1002/jum.15655 · Cited by 29
Factors associated with coronary heart disease in COPD patients and controls
Svendsen, C. D., Kuiper, K. K. J., Ostridge, K., Larsen, T. H., Nielsen, R., Hodneland, V., Nordeide, E., Bakke, P. S., & Eagan, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265682 · Cited by 29
Association between all-cause and cause-specific mortality and the GOLD stages 1–4: A 30-year follow-up among Finnish adults
Mattila, T., Vasankari, T., Kanervisto, M., Laitinen, T., Impivaara, O., Rissanen, H. A., Knekt, P., Jousilahti, P., Saarelainen, S., Puukka, P. J., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.06.002 · Cited by 29
Effect of Chronic Obstructive Pulmonary Disease on In-Hospital Mortality and Clinical Outcomes After ST-Segment Elevation Myocardial Infarction
Agarwal, M. A., Agrawal, S., Garg, L., Garg, A., Bhatia, N., Kadaria, D., & Reed, G. L. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.02.024 · Cited by 28
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review
Doehner, W., von Haehling, S., Anker, S. D., & Lainščak, M. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1194-7 · Cited by 28
COPD: Providing the right treatment for the right patient at the right time
Agustí, A. G. N., Ambrosino, N., Blackstock, F. C., Bourbeau, J., Casaburi, R. H., Celli, B. R., Criner, G. J., Crouch, R. H., Negro, R. W. D., Dreher, M., et al. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107041 · Cited by 32
Biological pathways and mechanisms linking COPD and cardiovascular disease
Ragnoli, B., Chiazza, F., Tarsi, G., & Malerba, M. (2025) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223251314286 · Cited by 34
The Risk of Erectile Dysfunction in Chronic Obstructive Pulmonary Disease
Shen, T., Chen, W., Lin, C., Chen, C., Tu, C., Hsia, T., Shih, C., Hsu, W., & Sung, F.-C. (2015) · Medicine · doi:10.1097/md.0000000000000448 · Cited by 27
Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?
Barton, A. K., & Gehlen, H. (2016) · Mediators of Inflammation · doi:10.1155/2016/5693205 · Cited by 27
Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients
Zagaceta, J., Bastarrika, G., Zulueta, J. J., Colina, I., Alcaide, A. B., Campo, A., Divo, M. J., Casanova, C., Marín, J. M., Pinto-Plata, V., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0658-y · Cited by 27
Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths
Strang, P. M., Fürst, P., Hedman, C., Bergqvist, J., Adlitzer, H., & Schultz, T. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01533-3 · Cited by 31
Chronic respiratory disease and multimorbidity: Prevalence and impact in a general practice setting
O’Kelly, S. M., Smith, S. M., Lane, S. J., Teljeur, C., & O'Dowd, T. C. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.07.019 · Cited by 27
Overcoming Gaps in the Management of Chronic Obstructive Pulmonary Disease in Older Patients
Gelberg, J., & McIvor, A. (2010) · Drugs & Aging · doi:10.2165/11535220-000000000-00000 · Cited by 27
Targeting Lung Inflammation: Novel Therapies for the Treatment of COPD
Rahman, I., Yao, H., & de Boer, W. I. (2008) · Current Respiratory Medicine Reviews · doi:10.2174/157339808783497873 · Cited by 27
COPD disease severity and the risk of venous thromboembolic events: a matched case–control study
Morgan, A. D., Herrett, E. L., Stavola, B. L. D., Smeeth, L. L., & Quint, J. K. (2016) · International Journal of COPD · doi:10.2147/copd.s100533 · Cited by 27
Long-term mortality follow-up of the ISOLDE participants: Causes of death during 13 years after trial completion
Bale, G., Martínez‐Camblor, P., Burge, P. S., & Soriano, J. B. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.001 · Cited by 27
DNA Methylation is Predictive of Mortality in Current and Former Smokers
Morrow, J. D., Make, B. J., Regan, E. A., Han, M. K., Hersh, C. P., Tal‐Singer, R., Quackenbush, J. F., Choi, A. M. K., Silverman, E. K., & DeMeo, D. L. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0439oc · Cited by 27
Low Erythropoietin Plasma Levels during Exacerbations of COPD
Sala, E., Balaguer, C., Villena, C., Ríos, Á., Noguera, A., Núñez, B., & Agustí, A. G. N. (2009) · Respiration · doi:10.1159/000264604 · Cited by 26
Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse model
Lee, H., Jung, K., Park, S., Kil, Y., Chung, E. Y., Jang, Y. P., Seo, E. K., & Bae, H. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-513 · Cited by 26
COPD: what is the unmet need?
Calverley, P. M. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.362 · Cited by 26
Lung Cancer and COPD: a Common Combination
Arca, J. A., Lamelas, I. P., Ortega, R. A., Pérez, J. J. B., Navarro, M. E. T., & Velázquez, P. M. (2009) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(09)73402-0 · Cited by 26
Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study
Liu, J., Yang, T.-Y., Hsu, Y.-P., Hao, W., Kao, P., Sung, L., Chen, C., & Wu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11162 · Cited by 27
Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study
Høiseth, A. D., Omland, T., Hagve, T., Brekke, P., & Søyseth, V. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-22 · Cited by 25
Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study
Chindhi, S., Thakur, S., Sarkar, M. S., & Negi, P. C. (2015) · Lung India · doi:10.4103/0970-2113.152624 · Cited by 25
Association of pulse wave velocity with total lung capacity: A cross-sectional analysis of the BOLD London study
Amaral, A. F. S., Patel, J., Gnatiuc, L., Jones, M. C., & Burney, P. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.10.016 · Cited by 25
Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: A “Vulnerable” Relationship
Sin, D. D., & MacNee, W. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1953ed · Cited by 25
Long-Term Oxygen Therapy in COPD: evidences and open questions of current indications
Corrado, A., Renda, T., & Bertini, S. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2010.311 · Cited by 24
Treating COPD in Older and Oldest Old Patients
Corsonello, A., Scarlata, S., Pedone, C., Bustacchini, S., Fusco, S., Zito, A., & Incalzi, R. A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150130121229 · Cited by 24
Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
Lin, C., Shih, C.-C., Yeh, C.-C., Hu, C., Chung, C., Chen, T.-L., & Liao, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169429 · Cited by 23
Models of care for non‐invasive ventilation in the Acute COPD Comparison of three Tertiary hospitals (ACT3) study
Parker, K., Perikala, V., Aminazad, A., Deng, Z. H., Borg, B. M., Buchan, C., Toghill, J., Irving, L. B., Goldin, J., Charlesworth, D., et al. (2017) · Respirology · doi:10.1111/resp.13228 · Cited by 24
Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B
Brat, K., Plutinský, M., Hejduk, K., Svoboda, M., Popelková, P., Zatloukal, J., Voláková, E., Fecaninova, M., Heribanová, L., & Koblížek, V. (2018) · International Journal of COPD · doi:10.2147/copd.s147262 · Cited by 24
Multimorbidity networks of chronic obstructive pulmonary disease and heart failure in men and women: Evidence from the EpiChron Cohort
Carmona‐Pírez, J., Poblador‐Plou, B., Díez‐Manglano, J., Morillo-Jiménez, M. J., Marín, J. M., Ioakeim‐Skoufa, I., Miguel, A. G., & Prados‐Torres, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111392 · Cited by 25
In People With COPD, There Is Limited Evidence That Exercise Training Reduces Sedentary Time, and Behavior Change Techniques Are Poorly Reported: Systematic Review and Meta-Analysis
Coll, F., Cavalheri, V., Gucciardi, D. F., Wulff, S., & Hill, K. (2021) · Physical Therapy · doi:10.1093/ptj/pzab097 · Cited by 25
Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease
Areias, V., Carreira, S., Anciães, M., Pinto, P., & Bárbara, C. (2014) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2013.09.001 · Cited by 24
Diastolic Dysfunction Is a Contributing Factor to Exercise Intolerance in COPD
Faludi, R., Hajdu, M., Vértes, V., Nógrádi, Á., Varga, N., Illés, M. B., Sárosi, V., Alexy, G., & Komócsi, A. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1084614 · Cited by 24
Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
Liu, S., Kuo, H., Liu, G.-H., Ho, S., Chang, H., Huang, H., Chen, Y., Huang, K., Chen, K., Fang, W., et al. (2016) · International Journal of COPD · doi:10.2147/copd.s106054 · Cited by 24
Chronic obstructive pulmonary disease and cardiac comorbidities: A cross-sectional study
Kaushal, M., Shah, P., Shah, A., Francis, S., Patel, N., & Kothari, K. (2016) · Lung India · doi:10.4103/0970-2113.184874 · Cited by 24
Causas de muerte en pacientes con EPOC grave. Factores pronósticos
Moreno, A., Montón, C., Belmonte, Y., Gallego, M., Pomares, X., & Real, J. (2009) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2008.09.004 · Cited by 24
Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease
Chubachi, S., Takahashi, S., Tsutsumi, A., Kameyama, N., Sasaki, M., Naoki, K., Soejima, K., Nakamura, H., Asano, K., & Betsuyaku, T. (2017) · International Journal of COPD · doi:10.2147/copd.s132709 · Cited by 24
Lung Disease and Hypertension
Imaizumi, Y., Eguchi, K., & Kario, K. (2014) · Pulse · doi:10.1159/000381684 · Cited by 25
INDACO project: COPD and link between comorbidities, lung function and inhalation therapy
Fumagalli, G., Fabiani, F., Forte, S., Napolitano, M., Balzano, G., Bonini, M., Simone, G. D., Fuschillo, S., Pentassuglia, A., Pasqua, F., et al. (2015) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-10-4 · Cited by 23
Enlightening chronic obstructive pulmonary disease through patients’ and caregivers’ narratives
Gatti, V., Banfi, P. I., Centanni, S., D'Antonio, S., Giustini, S. E., Piraino, A., Zibellini, M., & Marini, M. G. (2018) · International Journal of COPD · doi:10.2147/copd.s172214 · Cited by 23
Obstructive Sleep Apnea Increases the Prevalence of Hypertension in Patients with Chronic Obstructive Disease
Hu, W., Zhao, Z., Wu, B., Shi, Z., Dong, M., Xiong, M., Jiang, Y., Liu, D., Li, H., & Hu, K. (2020) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2020.1815688 · Cited by 22
Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: Results from the Phase I Data of ACURE Study
Liang, C., Mao, X., Niu, H., Huang, K., Dong, F., Chen, Y., Huang, K., Zhan, Q., Huang, Y., Zhang, Y., et al. (2021) · International Journal of COPD · doi:10.2147/copd.s281957 · Cited by 23
Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients
Reumkens, C., Endres, A., Simons, S. O., Savelkoul, P. H. M., Sprooten, R. T. M., & Franssen, F. M. E. (2023) · ERJ Open Research · doi:10.1183/23120541.00569-2022 · Cited by 23
Profiling hospital performance to monitor the quality of care: the case of COPD
Agabiti, N., Belleudi, V., Davoli, M., Forastiere, F., Faustini, A., Pistelli, F., Fusco, D., & Perucci, C. A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00056209 · Cited by 23
The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease
Balfe, D. L., French, A. N., Mirocha, J., Falk, J., & Mosenifar, Z. (2015) · International Journal of COPD · doi:10.2147/copd.s76739 · Cited by 24
Fibrinogen and COPD: Now what?
Faner, R., & Agustí, A. G. N. (2014) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2.1.2014.0127 · Cited by 24
Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort
Gagnat, A. A., Gjerdevik, M., Gallefoss, F., Coxson, H. O., Gulsvik, A., & Bakke, P. S. (2017) · European Respiratory Journal · doi:10.1183/13993003.01162-2016 · Cited by 23
Narrative medicine educational project to improve the care of patients with chronic obstructive pulmonary disease
Cappuccio, A., Sanduzzi, A., Verga, M., Nardini, S. G., Policreti, A., Porpiglia, P. A., Napolitano, S., & Marini, M. G. (2018) · ERJ Open Research · doi:10.1183/23120541.00155-2017 · Cited by 26
Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients
Pahus, L., Burgel, P., Roche, N., Paillasseur, J.-L., & Chanez, P. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0882-y · Cited by 23
Association of NLRP1 Coding Polymorphism with Lung Function and Serum IL-1β Concentration in Patients Diagnosed with Chronic Obstructive Pulmonary Disease (COPD)
Ozretić, P., Filho, M. I. D. S., Catalano, C., Sokolović, I., Vukić-Dugac, A., Šutić, M., Kurtović, M., Bubanović, G., Popović‐Grle, S., Škrinjarić-Cincar, S., et al. (2019) · Genes · doi:10.3390/genes10100783 · Cited by 23
Ebselen reduces cigarette smoke‐induced endothelial dysfunction in mice
Brassington, K., Chan, S. M. H., Seow, H. J., Dobric, A., Bozinovski, S., Selemidis, S., & Vlahos, R. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15400 · Cited by 23
Increased Relative Mortality in Women With Severe Oxygen-Dependent COPD
Ekström, M. P., Franklin, K. A., & Ström, K. (2009) · CHEST Journal · doi:10.1378/chest.09-0636 · Cited by 23
Factores pronósticos en la EPOC
Soler‐Cataluña, J. J., & Martínez‐García, M. Á. (2007) · Archivos de Bronconeumología · doi:10.1157/13112967 · Cited by 22
A person-centred clinical approach to the multimorbid patient with COPD
Celli, B. R., Fabbri, L. M., Yohannes, A. M., Hawkins, N. M., Criner, G. J., Bon, J. M., Humbert, M. J. C., Jenkins, C. R., Pantoni, L., Papi, A. A., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.020 · Cited by 26
Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation
Janson, C., Nwaru, B. I., Wiklund, F., Telg, G., & Ekström, M. P. (2020) · International Journal of COPD · doi:10.2147/copd.s276819 · Cited by 24
Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review
Mintz, M. L., Barjaktarević, I., Mahler, D. A., Make, B. J., SKOLNIK, N., Yawn, B. P., Zeyzus-Johns, B., & Hanania, N. A. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.09.007 · Cited by 22
Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study
Vogelmeier, C. F., Friedrich, F. W., Timpel, P., Kossack, N., Diesing, J., Pignot, M., Abram, M., & Halbach, M. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107506 · Cited by 22
Meta-analysis of routine blood tests as predictors of mortality in COPD
Lomholt, F. K., Laulund, A. S., Bjarnason, N. H., Jørgensen, H. L., & Godtfredsen, N. S. (2014) · European Clinical Respiratory Journal · doi:10.3402/ecrj.v1.24110 · Cited by 22
Comorbilidades em doentes com doença pulmonar obstrutiva crónica estádio IV
Areias, V., Carreira, S., Anciães, M., Pinto, P., & Bárbara, C. (2013) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppneu.2013.02.004 · Cited by 22
Systematic Review and Meta-Analysis of Pulmonary Hypertension Specific Therapy for Exercise Capacity in Chronic Obstructive Pulmonary Disease
Park, J., Song, J. H., Park, D. A., Lee, J. S., Lee, S., & Oh, Y. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.8.1200 · Cited by 22
Predictors of All-Cause Mortality in Patients with Stable COPD: Medical Co-morbid Conditions or High Depressive Symptoms
Maters, G. A., de Voogd, J. N., Sanderman, R., & Wempe, J. B. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.898026 · Cited by 21
ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
Crosbie, P. A. J., Crosbie, E. J., Aspinall-O’Dea, M., Walker, M., Harrison, R., Pernemalm, M., Shah, R. D., Joseph, L., Booton, R., Pierce, A., et al. (2016) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2015-000114 · Cited by 22

Authors: Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G.
Affiliations: St. Paul's Hospital (CA)
London School of Hygiene & Tropical Medicine (GB)
ORCID: Sin, D. D.
Soriano, J. B.
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2006-11-30
Volume: 28
Issue: 6
Pages: 1245-1257
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/09031936.00133805
OpenAlex: W2118228748
Cited by: 1,052
References: 142
Citations by year: 2026: 22 · 2025: 44 · 2024: 43 · 2023: 40 · 2022: 36 · 2021: 60 · 2020: 61 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 76 · 2015: 61 · 2014: 77 · 2013: 74 · 2012: 51
FWCI: 7.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
Funders: AstraZeneca
GlaxoSmithKline
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: chronic obstructive pulmonary disease, COPD mortality, comorbidities, cardiovascular disease, lung cancer, low-grade inflammation, respiratory failure, FEV1, BODE index, St George's Respiratory Questionnaire, mortality prediction, health assessment
MeSH terms: Health Status, Humans, Comorbidity, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mortality in COPD: role of comorbidities

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks